Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$59K Sell
1,306
-748
-36% -$33.1K 0.27% 297
2020
Q2
$131K Buy
+2,054
New +$83K 0.09% 99
2019
Q4
Sell
-6,114
Closed -$311K 496
2019
Q3
$311K Buy
6,114
+597
+11% +$31.2K 0.2% 339
2019
Q2
$304K Hold
5,517
0.25% 316
2019
Q1
$322K Buy
5,517
+3,425
+164% +$201K 0.28% 241
2018
Q4
$108K Sell
2,092
-758
-27% -$44.8K 0.07% 374
2018
Q3
$181K Buy
+2,850
New +$182K 0.29% 205
2018
Q2
Sell
-3,183
Closed -$194K 491
2018
Q1
$194K Buy
3,183
+1,129
+55% +$74.8K 0.25% 52
2017
Q4
$131K Buy
+2,054
New +$120K 0.09% 99

Other funds holding NUE

Cerebellum's NUE Position: Q3 2020 in Review

Cerebellum reduced its Nucor (NUE) stake by 36% in Q3 2020, selling an estimated $33.1K and leaving 1,306 shares worth $59K. The position accounts for 0.27% of the portfolio, ranked #297.

Cerebellum first reported a position in NUE in Q4 2017 and has held it in 9 quarters since. The position peaked at $322K in Q1 2019. 688 funds tracked by Wall St. Rank hold NUE as of Q3 2020.

  • Cerebellum held 1,306 shares of Nucor worth $59K as of Q3 2020.
  • Cerebellum sold 748 Nucor shares in Q3 2020, an estimated $33.1K.
  • Nucor made up 0.27% of Cerebellum's portfolio in Q3 2020, its #297 holding.
  • Cerebellum first reported a position in Nucor in Q4 2017 and has held it in 9 quarters since.
  • Cerebellum's Nucor position peaked at $322K in Q1 2019.
  • 688 funds tracked by Wall St. Rank held Nucor as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.